Skip to main content
. 2020 Jan 30;6(4):528–534. doi: 10.1001/jamaoncol.2019.6276

Figure 3. Stratified Overall Survival Analysis in Subgroups.

Figure 3.

CDCT indicates conventional-dose chemotherapy; ER+, estrogen receptor–positive; ERBB2, Erb-B2 receptor tyrosine kinase 2 negative; ERBB2+, Erb-B2 receptor tyrosine kinase 2 positive; HDCT, high-dose chemotherapy; and OS, overall survival.